Skip to content

RG+A

  • About Us
    • RG+A Customer Creed
    • Culture
    • Our Core Values
    • Senior Staff
      • Roger Green
      • Ali Spiro
      • Bruce Duncan, Ph.D.
    • Testimonials
  • Our Work
    • Our Experience
      • Treatment Areas and Therapeutic Drug Classes
    • Expert Insights
      • Enhancing forecast precision by simulating patient treatments
      • Presentation: Forecast Treatment across Multiple Therapy Lines
      • Doing More with Less: Utilizing Small Sample Analytics to Get the Most Out of Your Research Budget
      • Forecasting Physician Treatment Decisions across Multiple Lines of Therapy
      • Better Answers with Imprecise Data
      • Attribute Importance Ratings: Are We Learning Anything We Don’t Already Know?
    • Case Studies
      • Product Positioning for an Innovative In-Home Medical Device
      • Hazardous Drug Detection for Employee Safety
      • Assessing Market Potential and Development Strategy
      • Pricing and Volumetric Forecasting for an Orphan Drug
      • Using DPS®/Conjoint to Formulate a Competitive Response
      • Forecasting for Multiple Indications within the ADHD Market
      • Using Co-Creation to Support Optimal Product Profile Development and Clinical Trial Design
      • Applying Dynamic Practice Simulation (DPS) to Development and Commercialization Strategy
      • Contracting Strategy Development using Qualitative Conjoint to Segment Community Oncology Practice Managers
      • Forecasting and Strategy Development for a Neurological Product
      • Feature Optimization via Qualitative Conjoint to Combat Competitive Threat in the Vascular Device Space
  • Areas of Expertise
  • Methodologies
    • Iterative On-Line Qualitative Methods
    • Risk and Opportunity Assessment
    • Simulated Prescribing
  • News
  • Contact
    • Challenge Us
  • Careers

Areas of Expertise

Demand Forecasts

We simulate market behavior to create demand forecasts up to five years in the future. 

How we can help:  Simulating Prescribing and Risk and Opportunity Assessment 

 

Market Strategies

We pinpoint market drivers that create pathways or barriers in the successful commercialization of drugs, diagnostics, and devices.

How we can help: Iterative On-Line Qualitative Methods and Risk and Opportunity Assessment

 

News

  1. Dec 27, 2019

    RG+A to deliver presentation at PMRC 2020

  2. Dec 2, 2019

    RG+A Supports Innovative Women Advancing Health Tech – a $50B industry by 2025

  3. Mar 29, 2018

    Featured in Quirk’s Magazine: Roger Green discusses enhancing forecast precision by simulating patient treatments

  4. Mar 28, 2018

    Data Visualization Part 4: Telling a story

  5. Mar 21, 2018

    Data Visualization Part 3: Supporting ease of interpretation

  • About Us
    • RG+A Customer Creed
    • Culture
    • Our Core Values
    • Senior Staff
      • Roger Green
      • Ali Spiro
      • Bruce Duncan, Ph.D.
    • Testimonials
  • Our Work
    • Our Experience
      • Treatment Areas and Therapeutic Drug Classes
    • Expert Insights
      • Enhancing forecast precision by simulating patient treatments
      • Presentation: Forecast Treatment across Multiple Therapy Lines
      • Doing More with Less: Utilizing Small Sample Analytics to Get the Most Out of Your Research Budget
      • Forecasting Physician Treatment Decisions across Multiple Lines of Therapy
      • Better Answers with Imprecise Data
      • Attribute Importance Ratings: Are We Learning Anything We Don’t Already Know?
    • Case Studies
      • Product Positioning for an Innovative In-Home Medical Device
      • Hazardous Drug Detection for Employee Safety
      • Assessing Market Potential and Development Strategy
      • Pricing and Volumetric Forecasting for an Orphan Drug
      • Using DPS®/Conjoint to Formulate a Competitive Response
      • Forecasting for Multiple Indications within the ADHD Market
      • Using Co-Creation to Support Optimal Product Profile Development and Clinical Trial Design
      • Applying Dynamic Practice Simulation (DPS) to Development and Commercialization Strategy
      • Contracting Strategy Development using Qualitative Conjoint to Segment Community Oncology Practice Managers
      • Forecasting and Strategy Development for a Neurological Product
      • Feature Optimization via Qualitative Conjoint to Combat Competitive Threat in the Vascular Device Space
  • Areas of Expertise
  • Methodologies
    • Iterative On-Line Qualitative Methods
    • Risk and Opportunity Assessment
    • Simulated Prescribing
  • News
  • Contact
    • Challenge Us
  • Careers

RG+A
480 Union Square Drive
New Hope, PA 18938

Directions

Phone: (267) 744-6400
Fax: (267) 744-6499

Contact Us

Proud members of:

Intellus
Copyright © 2020 Roger Green and Associates, Inc. All rights reserved.